EDP-514, a potent pangenotypic class II hepatitis B virus core inhibitor, demonstrates significant HBV DNA and HBV RNA reductions in a phase 1b study in viremic, chronic hepatitis B patients

EDP-514, a potent pangenotypic class II hepatitis B virus core inhibitor, demonstrates significant HBV DNA and HBV RNA reductions in a phase 1b study in viremic, chronic hepatitis B patients

Saved in:
Bibliographic Details
Published in:Journal of hepatology Vol. 77; p. S849
Main Authors: Yuen, Man-Fung, Chuang, Wan-Long, Peng, Cheng-Yuan, Jeng, Rachel Wen-Juei, Su, Wei-Wen, Chang, Ting-Tsung, Chen, Chi-Yi, Hsu, Yao-Chun, De Rosa La, Guy, Ahmad, Alaa, Luo, Ed, Conery, Annie, Adda, Nathalie
Format: Journal Article
Language:English
Published: 01-07-2022
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0168-8278
DOI:10.1016/S0168-8278(22)01995-X